NOXAFIL conc perf 300 mg/16.7ml flac
7680651720019
CH-65172
J02AC04
08.06.0.
Reimbursement limitations:
NOXAFIL3
La prophylaxie chez des patients à risque élevé (voir 1a et 1b) peut être prescrite …
1 / 3
google
Details
- Product number
- 6517201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- posaconazolum 300 mg, sulfobutylbetadexum natricum 6680 mg, dinatrii edetas, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile ad solutionem pro 16.7 ml corresp. natrium 462 mg.
Articles (1)
Noxafil 300mg (18mg/ml), Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
6680.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
462.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 456.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2017
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 65172
- Drug name
- Noxafil, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- J02AC04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/12/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NOXAFIL 300mg (18mg/ml) sol inj 300 mg 1 pce
- Description (DE)
- NOXAFIL 300mg (18mg/ml) Inj Lös 300 mg 1 Stk
- Market launch
- 16/12/2015
- Narcotic (BTM)
- No